Cagrilintide has pharmacokinetic properties compatible with once-weekly administration, with an elimination terminal half-life ( t 1/2 ) of approximately 180 h (7.5 days) [7]
This is especially true during pregnancy, where NO helps control the feto-lacental circulation
Overall, neonatal pain management and sedation encounter gaps in evidence and practice, emphasizing the need for standardization, improved personalized approaches based on pharmacokinetic and pharmacodynamic maturation, multimodal strategies to minimize opioid and benzodiazepine exposure, and rigorous studies of new therapies to ensure safe, effective, and equitable care for newborns
Upon waking, skin looks plumper and feels softer thanks to the intense hydration
For best results, rotate injection sites and avoid eating for 3060 minutes before dosing